Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037957 · ClinicalTrials.gov registry record
A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 704
- Enrollment target
NCT03037957 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 704 participants.
The verdict
NCT03037957 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 704 participants
- Enrollment target
Study Summary
A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.
Interventions
- DEVICE ARIES Group A Strep Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 704 participants |
| Start Date | 2017-01-09 |
| Est. Completion | 2017-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03037957
The ClinicalTrials.gov registry entry for NCT03037957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 704 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminex Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ARIES Group A Strep Assay is the first listed.
NCT03037957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03037957 about?
NCT03037957 is a clinical study titled "A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients". A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.
What is the current status of trial NCT03037957?
This trial is currently completed. The enrollment target is 704 participants. The study started on 2017-01-09. Estimated completion is 2017-06-02.
What interventions are being tested in trial NCT03037957?
The interventions under investigation include: ARIES Group A Strep Assay (DEVICE).
Who is sponsoring clinical trial NCT03037957?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.